Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Conditioning and opiate withdrawal

The amygdala links neutral stimuli with the agony of overcoming drug addiction.

Abstract

The habitual behaviour of many opiate addicts means that the aversive symptoms of drug withdrawal are frequently experienced in specific environments1. Stimuli in these environments acquire some of the negative affective properties of opiate withdrawal through pavlovian conditioning, and subsequent exposure to these stimuli alone can then elicit a conditioned withdrawal response that is often associated with drug craving, drug seeking, and relapse back to compulsive drug use after a long abstinence1,2. We show here that selective excitotoxic lesions of the basolateral amygdala, part of the limbic forebrain, prevent the development of conditioned withdrawal in morphine-dependent rats.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Basolateral amygdala lesions significantly attenuate the conditioned withdrawal produced by a tone/light conditioned stimulus (CS) paired with naloxone during four conditioning trials.

References

  1. 1

    Wikler, A. Arch. Gen. Psychiatry 28, 611–616 (1973).

    Google Scholar 

  2. 2

    O'Brien, C. P., Testa, T., O'Brien, T. J., Brady, J. P. & Wells, B. Science 195, 1000–1002 (1977).

    Google Scholar 

  3. 3

    Koob, G. F. & Le Moal, M. Science 278, 52–58 (1997).

    Google Scholar 

  4. 4

    Schulteis, G. & Koob, G. F. Neurochem. Res. 21, 1437–1454 (1996).

    Google Scholar 

  5. 5

    Koob, G. F., Wall, T. L. & Bloom, F. E. Psychopharmacology 98, 530 –534 (1989).

    Google Scholar 

  6. 6

    Whitelaw, R. B., Markou, A., Robbins, T. W. & Everitt, B. J. Psychopharmacology 127, 213–224 (1996).

    Google Scholar 

  7. 7

    Everitt, B. J. et al. Ann. NY Acad. Sci. 877, 412– 438 (1999).

    Google Scholar 

  8. 8

    Baldwin, H. R. & Koob, G. F. Neuropsychopharmacology 8, 15–21 (1993).

    Google Scholar 

  9. 9

    Everitt, B. J., Cardinal, R. N., Hall, J., Parkinson, J. & Robbins, T. W. in The Amygdala: A Functional Analysis (ed. Aggleton, J.) (Wiley, New York, in the press).

  10. 10

    Aston-Jones, G., Delfs, J. M., Druhan, J. & Zhu, Y. Ann. NY Acad. Sci. 877, 486–498 ( 1999).

    Google Scholar 

  11. 11

    Groenewegen, H. J., Wright, C. I. & Beijer, A. V. J. Progr. Brain Res. 107, 485–511 (1996).

    Google Scholar 

  12. 12

    Schulteis, G., Markou, A., Gold, L. H., Stinus, L. & Koob, G. F. J. Pharmacol. Exp. Ther. 271, 1391–1398 (1994).

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to B. J. Everitt.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schulteis, G., Ahmed, S., Morse, A. et al. Conditioning and opiate withdrawal. Nature 405, 1013–1014 (2000). https://doi.org/10.1038/35016630

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing